Early Results of Acellular Dermal Matrix as an Interpositional Allograft Following Excision Arthroplasty of a Rheumatoid Forefoot: A Case Report
References
- Kim SJ, Gil YW, Sung IH. Preoperative patient's expectations and clinical outcomes after rheumatoid forefoot deformity reconstruction by joint sacrificing surgery. J Rheum Dis. 2024; 31(1): 33-40. doi: 10.4078/jrd.2023.0044
- Diniz P, Pacheco J, Flora M, Quintero D, Stufkens S, Kerkhoffs G, et al. Clinical applications of allografts in foot and ankle surgery. Knee Surg Sports Traumatol Arthrosc. 2019; 27(6): 1847-72. doi: 10.1007/s00167-019-05362-0
- Berlet GC, Hyer CF, Lee TH, Philbin TM, Hartman JF, Wright ML. Interpositional arthroplasty of the first MTP joint using a regenerative tissue matrix for the treatment of advanced hallux rigidus. Foot Ankle Int. 2008; 29(1): 10-21. doi: 10.3113/FAI.2008.0010
- Loveday DT, Jackson GE, Geary NP. The rheumatoid foot and ankle: current evidence. Foot Ankle Surg. 2012; 18(2): 94-102. doi: 10.1016/j.fas.2011.06.001
- Stilwell R, Delaney R. The biomechanics of Allomend® acellular dermal matrix: biocompatibility study. AlloSource White Paper. 2016; 00088-LIT[001].
Abstract | Reference
